Clinical Performance of B-Lite Light Weight Breast Implant

  • STATUS
    Recruiting
  • End date
    Dec 26, 2025
  • participants needed
    120
  • sponsor
    G&G Biotechnology Ltd.
Updated on 26 April 2021

Summary

This is a post-marketing study for B-Lite implants that carry the EC certificate for marketing in Europe and AMAR certificate for marketing in Israel. To date, thousands of implants have already been implanted in women. The study is open for primary augmentation patients only. All surgeries will be performed as per standard practice at the given study site. No parallel surgical procedures will be performed at the same session.

Details
Condition Breast Implant, Breast Prosthesis Implantation, Breast Implants
Treatment B-Lite- Light Weight Breast Implants
Clinical Study IdentifierNCT02777476
SponsorG&G Biotechnology Ltd.
Last Modified on26 April 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Genetic women between the ages of 18 and 60 seeking primary breast augmentation
Patient is eligible to undergo MRI (i.e., no implanted metal or metal devices, no history of severe claustrophobia)
Patient provides signed informed consent
Patient agrees to comply with the study protocol and complete all required follow up visits, including to undergo MRI
Patient agrees to return the device to the Sponsor should the implant have to be explanted
The patient has realistic expectations of surgical results after discussion with investigator and is an acceptable candidate for breast augmentation

Exclusion Criteria

Patients with active infection anywhere in their body
Patient is pregnant or nursing at the time of recruitment, or has been in the 6 months preceding recruitment date, or not willing to use reliable means of contraception during the first year after surgery
Patient was implanted with any silicone implant other than breast implants (e.g., silicone artificial joints or facial implants)
Patient breast tissue is clinically incompatible for the procedure (e.g., tissue damage resulting from radiation, insufficient tissue coverage or compromised vascularity)
Patient has a condition, or is under treatment for any condition, which, in the opinion of the investigator and/or consulting physician(s), may constitute an unwarranted surgical risk (e.g., unstable cardiac or pulmonary problems, possible allergies and/or extraordinary immune response to implant)
The patient has a history of mental instability and/or history of pharmaceutical psychiatric treatment
Patient unable to understand the scope of the study and/or surgery
The patient has any disease, including uncontrolled diabetes (e.g., HbA1c > 8%), that is clinically known to impact wound healing ability
Patient has existing costal injuries
Patient has abscesses, malignant tumors (cancer or recurrent metastases), clinically relevant cysts or advanced fibrotic disease or patient with BIRAD 3
Are not willing to undergo further surgery for revision, if medically required
The patient has a confirmed rheumatic disease or syndrome (e.g., SLE, Sjogren's syndrome, scleroderma, polymyositis or any connective tissue disorder, rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, any other inflammatory arthritis, fibromyalgia or chronic fatigue syndrome)
The patient has a severe breast and upper trunk deformity
The patient participated in an investigational trial within 90 days of enrollment
The patient has undergone an invasive medical procedure within 90 days of enrollment
Aesthetic addiction, drug abuse, alcohol abuse
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note